Related Experiment Video
Updated: Jul 6, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Oxidative and inflammatory pathways in Parkinson's disease
Rebecca L Miller1, Marilyn James-Kracke, Grace Y Sun
1Department of Medical Pharmacology and Physiology, University of Missouri - Columbia, Columbia, MO, 65212, USA.
Neurochemical Research
|March 26, 2008
Summary
Environmental toxins like MPTP, paraquat, and rotenone contribute to Parkinson's disease (PD) by inducing oxidative stress and activating glial cells. This review explores how these neurotoxins damage cells and pathways, leading to reactive oxygen species (ROS) production in PD.
Area of Science:
- Neuroscience
- Toxicology
- Pathology
Background:
- Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder.
- Key features include tremors, rigidity, and loss of dopaminergic neurons.
- The exact causes, including genetic and environmental factors, remain unclear.
Purpose of the Study:
- To review the pathological effects of environmental neurotoxins on cellular mechanisms in Parkinson's disease.
- To elucidate the role of oxidative stress and reactive oxygen species (ROS) in PD pathogenesis.
Main Methods:
- Review of existing literature on neurotoxins and Parkinson's disease.
- Analysis of studies involving cell and animal models.
- Examination of cellular signaling pathways involved in neuroinflammation and oxidative stress.
Main Results:
- Environmental toxins such as MPTP, paraquat, and rotenone are linked to increased PD risk.
- These toxins exhibit oxidative and inflammatory properties.
- Neurotoxins activate glial cells, leading to dopaminergic neuron destruction and ROS production.
Conclusions:
- Oxidative stress induced by environmental neurotoxins is a key factor in Parkinson's disease progression.
- Understanding these pathological pathways is crucial for developing therapeutic strategies for PD.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation